Melphalan is a chemotherapy drug belonging to the class of nitrogen mustard
alkylating agents. An alkylating agent adds an alkyl group to DNA. It attaches the
Drug type: Melphalan is an anti-cancer ("antineoplastic" or "cytotoxic")
chemotherapy drug. This medication is classified as an "alkylating agent." (For
more detail ...
Jan 3, 2016 ... Alkeran (melphalan) is a drug prescribed for the treatment of multiple myeloma
and ovarian cancer. Side effects of Alkeran include weight loss, ...
Jan 23, 2014 ... The chemotherapy drug melphalan can treat myeloma, advanced ovarian cancer
and advanced breast cancer. The possible side effects ...
May 2, 2016 ... Easy to read patient leaflet for melphalan. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Find patient medical information for melphalan oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
An alkylating nitrogen mustard that is used as an antineoplastic in the form of the
levo isomer – melphalan, the racemic mixture – merphalan, and the dextro ...
Jun 1, 2015 ... Melphalan, a bifunctional nitrogen mustard-derivative alkylating agent, is the ...
Melphalan inhibits DNA and RNA synthesis via formation of ...
melphalan hydrochloride: Patient Information: A bifunctional alkylating agent and
phenylalanine derivative of nitrogen mustard. Melphalan hydrochloride is ...
Mar 28, 2016 ... This page contains brief information about melphalan and a collection of links to
more information about the use of this drug, research results, ...